The QualityStocks Daily Friday, February 14th, 2020

Today's Top 3 Investment Newsletters

NetworkNewsWire (GNPX) +56.20%

MarketBeat (BTAI) +55.01%

QualityStocks (RRIF) +48.52%

The QualityStocks Daily Stock List

1847 Holdings LLC (EFSH)

OTC Markets, TipRanks, Barchart, Corporate Information, Accesswire, TradingView, Morningstar, Stockopedia, Real Investment Advice, Dividend.com, GuruFocus, CSI Market, Seeking Alpha, Simply Wall St, YCharts, last10k, Dividend Investor, Street Insider, Market Screener, and Wallet Investor reported previously on 1847 Holdings LLC (EFSH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

1847 Holdings LLC is an innovative publicly traded holding company platform. It combines the attractive attributes of private, lower-middle market businesses with the liquidity and transparency of a publicly traded company. The Company works to generate returns for shareholders in the future via consistent, annual distributions of operating subsidiary income and capital appreciation resulting from the timely sale of operating subsidiaries. 1847 Partners LLC serves as the manager of the company. 1847 Holdings LLC has its corporate headquarters in New York, New York.

The Company’s intention is to provide shareholders with non-correlated returns. This is while permitting shareholders to liquidate their position in 1847 Holdings LLC at any point during an investment timeline. 1847's innovative structure permits flow-through tax treatment for shareholders.

1847 Holdings looks to derive value creation by way of prudently distributing annual income while growing its operating subsidiaries. This is in comparison to financial engineering fostered by extreme leverage. Therefore, the Company seeks to own companies with founder-operators and management teams at the critical inflection point in their growth cycle.

1847 Holdings looks for businesses headquartered in North America and with Revenues of at least $5 million. It also looks for an historical Revenue growth rate of at least 5 percent. Moreover, it looks for companies that have current year EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of at least $1.5 million.

At the end of January, 1847 Holdings LLC announced that it signed a non-binding Letter of Intent (LOI) to acquire a multi-state retail hydroponic supply operation. In addition, it has created a new wholly-owned subsidiary, 1847 Hydroponic, Inc., in preparation of completing the transaction.

Mr. Ellery W. Roberts, Founder and Chief Executive Officer of 1847 Holdings, said, "This acquisition will give 1847 the ability to participate in the high-growth hemp and cannabis market without touching the plant or incurring the burdensome regulatory requirements and challenges of traditional cannabis operations focused on cultivation and end-product sales. With our team's extensive experience in high-growth retail operations, we're confident we can rapidly scale this business moving forward."

1847 Holdings LLC (EFSH), closed Saturday's trading session at $1.7499, up 24.9929%, on 332 volume with 2 trades. The average volume for the last 3 months is 135 and the stock's 52-week low/high is $1.00999999/$3.00.

Angkor Resources Corp. (ANKOF)

TeleTrader, Smart Stock Trading Strategies, Investing News, Investor Intel, InvestorX, Stockwatch, Market Screener, TradingView, Stockhouse, Junior Mining Network, GuruFocus, OilandGas360, Dividend.com, Geology for Investors, GlobeNewswire, MarketWatch, and Resource World reported beforehand on Angkor Resources Corp. (ANKOF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Angkor Resources Corp. is the first North American publicly-traded mineral and oil & gas exploration company in Cambodia. Its strategy focuses on project generation and selecting strong partners to advance each of its many prospects towards a sustainable recurring revenue stream. The Company formerly went by the name Angkor Gold Corp. It changed its corporate name to Angkor Resources Corp. in September of 2019. Incorporated in 2008, Angkor Resources is headquartered in Sexsmith, Alberta.

Angkor Resources has been working in the Kingdom of Cambodia since 2009. Cambodia has a resource-rich geology, favorable mining policies, and accessible and mineable topography. Angkor has a large land package and a new oil and gas exploration license that includes 7,300 square kilometers of Cambodia.

Angkor’s properties include Banlung (Okalla); Andong Meas; Oyadao; Oyadao South (Halo); and Koan Nheak. The Banlung property includes two chief prospects. These are Okalla West and Okalla East with gold mineralization associated with an alkaline intrusive complex.

Andong Meas is positioned 50 kilometers east of the provincial capital Banlung along a paved highway. Oyadao is a 222 km2 license area close to the Vietnam border. The Oyadao South License is about 247 sq. km. This license was renewed in 2017 for 3 years with extensions for an additional 4 years. The Oyadao South License contains several prospects, including the Halo Prospect. The Koan Nheak Licence is 189 km2. It lies immediately south of the town of the same name in the northeast of Mondulkiri Province.

In January, Angkor Resources reported that it signed an Earn-In Agreement on its Oyadao License with Canadian development company Hommy Oyadao, Inc. to earn up to a 70 percent interest in Angkor’s Oyadao North License in exchange for payments totalling USD $4.6 million. The Oyadao License mineral rights were sold separately by Angkor to Mesco in 2013 and licensed in 2016 for $1.8 million US in cash, with Angkor Resources retaining a sliding scale Net Smelter Return (NSR) interest ranging from 2.0 percent to 7.5 percent on any gold production, and also 7.5 percent of the value of all other metals produced.

Angkor Resources was pleased to facilitate a regional dental campaign in collaboration with an American dental team in northeastern Cambodia last month. Dental Campaign 2020 took place from January 1 to 4. It provided free and much needed dental care to indigenous people and rural village members from more remote parts of the Company’s exploration license areas, including Oyadao and Andong Meas. Angkor Resources again worked with a highly qualified team of professional dental specialists who generously donated their time and skills.

Angkor Resources Corp. (ANKOF), closed Saturday's trading session at $0.072, up 3.0043%, on 19,500 volume with 2 trades. The average volume for the last 3 months is 940 and the stock's 52-week low/high is $0.063600003/$0.121699996.

Elev8 Brands, Inc. (VATE)

Whale Wisdom, OTC Markets, Spotlight Growth, Pennystocks.news, NIC Investors, MicroSmallCap, InvestorsHub, Marijuana Retail Report, StockTA.com, YCharts, Morningstar, Seeking Alpha, Stockhouse, Investors Hangout, FactsAboutCBD.org, Silicon Investor, Stockopedia, Dividend Investor, Stockwatch, Simply Wall St, GuruFocus, Insider Financial, Wallet Investor, Emerging Growth, Dividend.com, Ceo.ca, Barchart, TradingView, and Investing.com reported earlier on Elev8 Brands, Inc. (VATE), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Elev8 Brands, Inc. is a holding company listed on the OTC Markets Group’s OTCQB. It concentrates on the commercial development of hemp and cannabinoid-infused beverages along with a variety of CBD (cannabidiol) topicals and tinctures. The Company previously went by the name PLAD, Inc. It changed its name to Elev8 Brands, Inc. in December of 2016. The Company has its head office in Longwood, Florida.

Elev8 Brands’ corporate mission is to craft the highest-quality, organic hemp products for consumers in search of a healthier, happier lifestyle. The Company sources only the best organic hemp protein powders (naturally full of powerhouse amino acids and Omegas-3, 6, and 9). Therefore, it can infuse its customers daily coffee and tea with an abundance of minerals, vitamins, antioxidants, as well as fiber. Elev8 Hemp takes these raw, natural products and transforms them into CBD-infused beverages. CBD-infused coffees and teas are the Company’s specialty.

Last month, Elev8 Brands, Inc. announced that it connects with athletes looking to improve their health and performance through CBD use in its new partnership with Linda Bos of Outwest 505 Distributing and the New Mexico Runners, a professional arena soccer team based in Rio Rancho, New Mexico. The partnership comes as the New Mexico Runners begin their second professional area soccer team season in the Major Arena Soccer League 2 and as Outwest 505 Distributing expands its presence in New Mexico and expands the business into Arizona.

Mr. Ryan Medico, Elev8 Hemp's Chief Executive Officer, said, "Linda has been incredible to work with. It's strong partnerships like this one that get us excited about our continued growth in the CBD space. We hope to build upon our success in the new year and continue to align Elev8 Hemp with organizations like the New Mexico Runners who immediately understand the value of our products."

Elev8 Brands, Inc. (VATE), closed Saturday's trading session at $0.0164, up 1.8634%, on 237,694 volume with 19 trades. The average volume for the last 3 months is 1,203,960 and the stock's 52-week low/high is $0.011099999/$0.0579.

Gran Colombia Gold Corp. (TPRFF)

Resource World, Junior Mining Network, Street Insider, Micro Small Cap, Market Screener, Metals News, Mining & Energy, TradingView, Mining Stock Education, Stockhouse, Gold Stock Data, Wallet Investor, Stockwatch, Northern Miner, The Prospector News, GuruFocus, and Dividend.com reported beforehand on Gran Colombia Gold Corp. (TPRFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Gran Colombia Gold Corp. is a mid-tier gold producer. Its principal emphasis is in Colombia where it is now the largest underground gold and silver producer with several mines in operation at its Segovia and Marmato Operations. The Company is presently in the midst of an expansion and modernization project at its high grade, production stage Segovia Operations. Gran Colombia Gold has its corporate office in Toronto, Ontario. The Company’s shares trade on the OTC Markets Group’s OTCQX.

Gran Colombia’s focus is on the development of the Segovia Operations and Marmato projects to produce strong cash flows in the short, medium, as well as long term. The Company produces gold from the Segovia Operations, an area of approximately 9,000 hectares in the Segovia-Remedios mining district of Antioquia. The Segovia Operations include the El Silencio, Providencia, and Sandra K underground mines in the Municipality of Segovia, and the Carla underground mine in the Municipality of Remedios, positioned about 10 km southeast of the Segovia mines.

The Marmato Project contains total estimated resources of roughly 8 million ounces of gold and almost 38 million ounces of silver situated in the Caldas department in the heart of the Middle Cauca gold district. The Marmato Project has first-class infrastructure, being located by the Pan American Highway with access to Medellin to the north and Manizales to the south. It has access to the national electricity grid which runs near the property.

Gran Colombia Gold also has its Zancudo project. The Zancudo project is in the Titiribí mining district of Antioquia. It comprises an historical gold mine, the Independencia Mine, in the Middle Cauca Gold Belt, which produced approximately 130,000 ounces of gold with recovered grades of 14.6 g/t Au and 108.4 g/t Ag.

Last week, Gran Colombia Gold announced that it closed its earlier announced non-brokered Private Placement of 7,142,857 Units of the Company at a price of CA$5.60 per Unit for total proceeds of CA$40 million. Gran Colombia also announced that it will use a portion of the net proceeds of the Private Placement to redeem 30%, equivalent to US$19,162,500, of the aggregate principal amount outstanding of its 8.25% Senior Secured Gold-Linked Notes due 2024 on March 31, 2020 (Redemption Date), decreasing the aggregate principal amount outstanding to US$44,712,500.

Mr. Serafino Iacono, Executive Chairman of Gran Colombia Gold, stated, “We are pleased to see Mr. Sprott, a well-known gold investor, increase his stake in Gran Colombia to over 10% and to welcome investment from other key strategic and institutional investors. While our operations continue to generate free cash flow, we believe the opportunity to apply a significant portion of the net proceeds of this private placement toward a further deleveraging of our balance sheet creates value for our shareholders, particularly in the current gold price environment, enabling us to reduce our debt service ahead of schedule and preserving for our shareholders the gold premium we would otherwise be paying on the Gold Notes we intend to redeem.”

Gran Colombia continues to concentrate on exploration, expansion and modernization activities at its high-grade Segovia Operations and, via a spin out transaction with Bluenose Gold Corp. announced on October 7, 2019, is progressing toward a significant expansion and modernization of its underground mining operations at the Marmato Project.

Gran Colombia Gold Corp. (TPRFF), closed Saturday's trading session at $4.41, up 3.9677%, on 78,165 volume with 169 trades. The average volume for the last 3 months is 24,687 and the stock's 52-week low/high is $2.29859995/$4.5999999.

International Spirits & Wellness Holdings, Inc. (ISWHD)

Spotlight Growth, OTC.Watch, OTC Markets, Market Screener, NewMediaWire, Undergroundstocks, Journal Transcript, Investor Ideas, Investor News, OTC PR Wire, Financial Buzz, Stock News Feed, and Stockaholics reported earlier on International Spirits & Wellness Holdings, Inc. (ISWHD), and today we report on the Company, here at the QualityStocks Daily Newsletter.

International Spirits & Wellness Holdings, Inc. (ISWHD) is a top-tier brand incubator in the Global Wine & Spirits and CBD-Infused Products and Home Healthcare markets. The Company is an authorized importer, licensor, and marketer of premium beverage brands, with sales of innovative products and brands worldwide. The Company formerly went by the name International Spirits & Beverage Group, Inc. It changed its name to International Spirits & Wellness Holdings, Inc. in July of 2019. ISWHD is Nevada based and lists on the OTC Markets.

ISWHD develops and grows brands through all phases. This includes concept creation, product development, market positioning, as well as sales and marketing. The Company’s goal is to be a global innovation leader within the alcohol beverage and cannabis industries. It will source early stage brands, existing brands with unrealized potential, and create in-house brands that raises innovation and expectations with trade and consumers.

In addition, ISWHD has partnered with Bengala Technologies. This partnership is for developing and commercializing enterprise and B2B (Business-to-Business) software technology products targeting the logistics and supply-chain marketplace with VOLUM.

ISWHD’s Wine and Spirit portfolio is led by Besado Tequila. This is its unique entrance within the growing ultra-premium tequila segment. Also, ISWHD’s Dziaq (dee-zee-ack) Liqueur re-brand to a wine based ready-to-serve cocktail line allows for considerably more distribution channels (2 x spirit based alternatives).

ISWHD’s latest brand is P19. This is the Company’s first entrance into the CBD (cannabidiol) space. It partnered with best-in-class CBD experts at BioPulse Labs. P19 was created around developing the finest CBD products such as gummies, topicals, tinctures, and more.

This past December, ISWHD announced the full execution by all parties of a partnership agreement with BioPulse Labs. The Agreement appoints BioPulse as ISWHD's exclusive manufacturing and marketing partner for the launch of five CBD-based wellness products. This will include a comprehensive branding refresh for ISWHD’s P19 CBD-based products brand, with all CBD-based products formulated and produced in FDA (Food and Drug Administration) compliant and registered facilities. BioPulse Labs is a leader in pioneering CBD nano-infusion formulation technology and CBD-based product brand development.

Yesterday, ISWHD updated shareholders on a number of key themes, including its recent reverse share split and restructuring. The Company performed a reverse split effective February 6, 2020.

Mr. Alonzo Pierce, President and Chairman of ISWHD, said, “A shareholder-friendly restructuring was necessary to strengthen our relationship with capital markets, pursue a near-term uplist to a higher exchange tier, and set in motion our operational strategy for 2020. We have a number of very compelling catalysts set to roll out, but we needed to provide a viable context – to lay a foundation for that success – as an initial step. We have achieved that with our restructuring and reverse split last week.”

International Spirits & Wellness Holdings, Inc. (ISWHD), closed Saturday's trading session at $0.483, up 0.835073%, on 3,222 volume with 12 trades. The average volume for the last 3 months is 22,175,248 and the stock's 52-week low/high is $0.109999999/$32.00.

Jacksam Corporation (JKSM)

StockAP, OTC.Watch, Stockopedia, Real Investment Advice, Stockwatch, Simply Wall St, Investors Hangout, last10k, GlobeNewswire, Insider Monitor, TradingView, Investors Hub, PR Newswire, and GuruFocus reported previously on Jacksam Corporation (JKSM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Jacksam Corporation is a workflow automation company centered on developing machinery and equipment solutions for the cannabis and CBD (cannabidiol) industry. The Company designs and markets proprietary automated vape, POD and cartridge filling/capping equipment for the cannabis industry. It serves the medical cannabis, hemp, and CBD segments of the e-cigarette and vaporizer markets with its oil vaporizer focused products. Jacksam is based in Rancho Santa Margarita, California. The Company lists on the OTC Markets’ OTCQB.

Jacksam’s automated equipment is designed and built in the USA. It carries the only full UL certification in the U.S. Using Jacksam/Convectium's automated equipment, its customers increase output by up to 60 times over hand filling. Jacksam/Convectium is focused on helping its customers automate their workflow and get custom branded products onto dispensary shelves fast. More than 100 companies, including many dominant brands in the space, rely on Jacksam/Convectium for automation of their filling operations.

The Company has adopted an “open source” business model enabling the majority of cannabis and CBD oil producers to benefit from its filling and capping equipment. Jacksam (shifting away from a closed system approach) has made its vape, POD and cartridge trays and equipment compatible with components produced by most of the top international manufacturers.

This past December, Jacksam announced that The Stock Day Podcast welcomed Jacksam Corporation. The President and Chief Executive Officer of the Company, Mr. Mark Adams, joined Stock Day host Everett Jolly. Jolly began the interview by commenting on Jacksam's partnership with Jupiter Research, LLC, and what it means for their future.

Mr. Adams said, "Jupiter is by far the leading C-Cell technology company selling in the United States and abroad. They bring a quality and research and development technology aspect to a partnership that we really value."

They then discussed the Company's revenue potential in 2020. Mr. Adams said, "We did a preliminary test on Jupiter customers, and estimated that there are over 500 customers that we can sell machines to and service together. Our agreement does allow us some royalty revenue. We think that the revenue opportunity is huge." Mr. Adams noted that Jacksam also expects the vaping industry to bounce back this year.

Jacksam Corporation (JKSM), closed Saturday's trading session at $0.164723, off by 1.9506%, on 4,048 volume with 5 trades. The average volume for the last 3 months is 2,868 and the stock's 52-week low/high is $0.150000005/$2.50.

Two Hands Corporation (TWOH)

OTC Markets, The Hot Penny Stocks, OTC Dynamics, StockReads, Market Wire News, Market Screener, TradingView, Simply Wall St, Stockhouse, last10k, Accesswire, CSI Market, YCharts, Barchart, InvestorsHub, Seeking Alpha, Global Banking and Finance, Investing.com, Morningstar, Stockwatch, Wallet Investor, and OTC.Watch reported beforehand on Two Hands Corporation (TWOH), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Two Hands Corporation is a foremost custom application development company. Its emphasis is on creating a complete co-parenting solution, delivering tools that enable co-parents to better collaborate about parental responsibilities, in a clear and positive way. The Company previously went by the name Innovative Product Opportunities, Inc. It changed its name to Two Hands Corporation in September of 2016. Established in 2009, the Company is headquartered in Toronto, Ontario. Two Hands Corporation’s shares trade on the OTC Markets.

The "Two Hands" web application launched in July of 2018. Two Hands Corporation’s ultimate objective is to improve the lives of families affected by divorce. The Company states that "Two Hands" is an ideal solution that will lessen the stress and worries of co-parenting.

Regarding Two Hands Corporation’s other offerings, the Company’s Gone App allows one to send encrypted text messages right from their phone, combining military-grade security, confidentiality, and privacy – with premier convenience, right at their fingertips. All text messages are asymmetrically encrypted. It is safe, with keys that only the rightful user owns. Gone App features Message Auto-Deletion after being read; no preview, one must click to view the message; and Screen Capture is disabled.

Moreover, Two Hands Corp Lab is an organic hemp based CBD (cannabidiol) cultivator located in Colombia. Two Hands Corp Lab is vertically integrated, producing from seed to wholesaler. It will distribute its high grade hemp based oil chiefly through Latin America and Australia. Additionally, it will expands its reach once countries allow for importation.

Last month, Two Hands Corporation announced it expected to release its IOS and Android Native Application shortly.

Nadav Elituv, Two Hands Corporation’s Chief Executive Officer, said "Our application is under review and final testing is under way. We believe version 2.0 will meet the requirements of co-parenting. This is a significant milestone for us, once launched on the Apple App store and Google Play store we will be able to provide greater access to our users."

Two Hands Corporation (TWOH), closed Saturday's trading session at $0.1219, up 0.743802%, on 307,774 volume with 116 trades. The average volume for the last 3 months is 2,270,841 and the stock's 52-week low/high is $0.075000002/$225.00.

China Health Industries Holdings, Inc. (CHHE)

Hot OTC Stocks, Zacks, The Hot Penny Stocks, Wallmine, InvestorsHub, MarketWired, Market Screener, Proactive Investors, OTC Markets, Simply Wall St, Stockhouse, Stock Earnings, Wallet Investor, YCharts, and GuruFocus reported previously on China Health Industries Holdings, Inc. (CHHE), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

China Health Industries Holdings, Inc. is a holding company vertically integrated with the operations in its subsidiaries in the People's Republic of China. It specializes in research and development (R&D), production, marketing and distribution of hemp derivative products, medicines and health supplement products. The Company has completed the strategic transformation from being a traditional health supplement products manufacturer to a hemp derivative products pioneer. OTCQB-listed, China Health Industries Holdings has its head office in Harbin, China.

The Company owns GMP certified plants and facilities. It manufactures 21 CFDA approved medicines and 14 health supplement products covering five types of dosage forms. These include soft capsule, hard capsule, tablet, granule, and oral liquid. Its product series encompass hemp derivative foods, hemp derivative medicines, externally used medicines and health foods. These products address important major markets such as women’s products, geriatric products, children’s products, and other important market sectors. Its hemp derivative products have been launched into the Chinese marketplace. This includes Hemp Oil, Hemp Protein Powder, Hemp Polypeptide as well as Hemp Cosmetics.

China Health Industries’ intention is to market much of its product line covering all of China and overseas countries. As a first step toward implementing its business plan, it strategically transferred its business to production, sales and R&D of Hemp-based products in 2018. It is working to establish sales centers and chain-stores to connect consumers closely with its products.

Recently, China Health Industries Holdings announced the financial results for its Q1 ended September 30, 2019. Mr. Xin Sun, Chief Executive Officer and Chairman of the Company, said, "We are pleased to report our financial results for the first quarter of our 2020 fiscal year. Our revenue decreased by 4.10 percent for the three months ended September 30, 2019, as compared to the same period in 2018. However, our net income increased by 19.67 percent for the three months ended September 30, 2019, as compared to the same period in 2018. We continue to focus on developing, manufacturing and distributing new hemp derivative products".

China Health Industries Holdings, Inc. (CHHE), closed Saturday's trading session at $0.8888, up 36.7385%, on 13,400 volume with 24 trades. The average volume for the last 3 months is 46 and the stock's 52-week low/high is $0.25/$1.75.

One World Pharma, Inc. (OWPC)

PennyStockBase, Stocks News Feed, Simply Wall St, Daily Marijuana Observer, NewMediaWire, PR Newswire, Street Insider, Dividend Investor, Investors Hangout, Oil and Gas 360, TradingView, Seeking Alpha, Stockwatch, Stockopedia, GlobeNewswire, and InvestorsHub reported previously on One World Pharma, Inc. (OWPC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

One World Pharma, Inc. is the U.S. parent company of One World Pharma S.A.S, which is a fully licensed cannabis and hemp producer with offices and operations in Bogota and Popayan, Colombia. The Company’s intention is to supply the highest quality cannabis and hemp derivatives in crude oil, distillate and isolate forms with industrial scale production to serve worldwide cannabis demand. One World Pharma products will be produced and tested to GMP and ISO standards. The Company lists on the OTC Markets. It has its U.S. office in Las Vegas, Nevada.

In 2018, One World Pharma planted its first crop of cannabis at its cultivation site in Popayan, Colombia, for research purposes. The Company expects to commence harvesting commercially in Q4 of this year. One World Pharma uses their wide-ranging knowledge and research of the cannabis plant to cultivate specific strains from around the world - with 25 registered strains at ICA (Instituto Colombiano Agropecuario) and dozens more awaiting approval.

In essence, One World Pharma is a large-scale producer of high-quality cannabis and hemp products for the medical and commercial markets. The Company has more cultivation facilities under contract in addition to its Popayan, Colombia (135KM south of Cali) facility. One World Pharma has been granted four licenses for the cultivation of Non-Psychoactive (Low) THC, Psychoactive (High) THC, and the manufacture of cannabis derivatives and seeds.

This past April, One World Pharma announced it was granted permission by ICA to start cultivating 13 proprietary high THC cannabis strains and 2 high CBD strains. The approval greatly speeds up the Company’s efforts as one of the first cultivators of scale in the highly desirable Colombian production environment.

One World Pharma’s next step will be to put these strains through characterization tests to confirm their genetic attributes, in particular local environments. Upon successful characterization tests, the Company will register these cannabis strains and genetics and be in a position to cultivate for commercial purposes. It anticipates getting permission to put additional strains through this process during 2019.

In May, One World Pharma announced that it entered into its first seed sale agreement in Colombia with Mr. Kevin Steven Ocampo Prieto of Bogota. Via this long term, evergreen agreement, the Company agreed to provide Mr. Prieto with seeds of its non-psychoactive cannabis strains that are in the registration procedure for the national register of commercial cultivars of the ICA.

One World Pharma, Inc. (OWPC), closed Saturday's trading session at $0.5489, up 48.3514%, on 213,006 volume with 50 trades. The average volume for the last 3 months is 8,425 and the stock's 52-week low/high is $0.370000004/$4.65000009.

Galaxy Next Generation, Inc. (GAXY)

Simply Wall St, Wallet Investor, Dividend Investor, GuruFocus, GlobeNewswire, Teletrader, Market Screener, Modest Money, Barchart, The Street, Investors Hangout, Corporate Information, Last10k, MarketWatch, and Street Insider reported on Galaxy Next Generation, Inc. (GAXY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Galaxy Next Generation, Inc. (GAXY) is a U.S. distributor of interactive learning technology hardware and software, which create totally collaborative instructional environments. The Company’s products include its own private-label interactive touch screen panel and many other national and international branded peripheral and communication devices. Galaxy Next Generation has its corporate headquarters in Toccoa, Georgia. The Company’s shares trade on the OTC Markets Group’s OTCQB.

Galaxy Next Generation’s distribution channel includes more than 22 resellers across the United States. These resellers mainly sell the Company’s products within the commercial and educational market. Typically, the K-12 education market is the largest customer base for Galaxy Next Generation products. This market comprises close to 90 percent of the Company's sales.

The Company works together with educators to help them develop teaching and learning in their Connected Classrooms. This new approach takes advantage of digital content, learning data, and one-of-a-kind technologies to create an immersive and interactive experience.

Galaxy’s products include interactive panels, collaboration devices, panel accessories, and integrated PCs. The Company’s software includes Ximbus and Oktopus. In addition, Galaxy offers an assortment of on-site training opportunities. The Company also focuses on premier after sales services.

In March, Galaxy Next Generation announced a new product offering where it has started to use online training resources for its products and customers. Mr. Gary LeCroy, Galaxy Next Generation’s Chief Executive Officer, said, “We now have reference cards available for the software and hardware, step by step instructions on using the software and hardware, and we are even offering onsite training at the customers school or place of business as part of their purchase.”

Furthermore, in March, Galaxy Next Generation announced that Newton County, Georgia, School District, a prior purchaser of G2 panels, will continue to purchase the Company’s G2 panel as a standard. Mr. LeCroy said, "We are excited to be the official company awarded Newton County School District’s G2 panel contract. It is always edifying to have an existing customer see the continued value of our products.”

Galaxy Next Generation, Inc. (GAXY), closed Saturday's trading session at $0.0693, up 35.7493%, on 433,669 volume with 44 trades. The average volume for the last 3 months is 143,963 and the stock's 52-week low/high is $0.045000001/$3.3900001.

SusGlobal Energy Corp. (SNRG)

Simply Wall St, Penny Stock Hub, Trading View, Wallstreet Online, Market Screener, Dividend Investor, Barchart, Investors Hangout, Stocks News Feed, GuruFocus, Street Insider, Interactive Brokers, Law Insider, last10k, YCharts, Morningstar, and MarketWatch reported on SusGlobal Energy Corp. (SNRG), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

SusGlobal Energy Corp. is the developer of SusGro™, which is a pioneering pathogen free organic fertilizer. The Company is a renewables business centered on acquiring, developing, and monetizing a portfolio of proprietary technologies in the waste to energy and regenerative products application worldwide. SusGlobal Energy has its head office in Toronto, Ontario. The Company lists on the OTC Markets Group’s OTCQB.

SusGlobal Energy has the capability to provide a complete range of services for handling organic residuals. The Company has spent years attaining proprietary processes and combining different treatments. It also has many years of innovative experience and technical knowledge and thus can provide its clients with comprehensive solutions. SusGlobal Energy has projects in Belleville, Ontario; Hamilton, Ontario; and Florida.

SusGlobal Energy can, from beginning to end, offer in-depth knowledge, abundant experience and trailblazing technology for all a client’s needs in handling organic waste. Some of the Company’s work managing organic waste streams includes Anaerobic Digestion, Dry Digestion, Biogas Production, Wastewater Treatment, In-Vessel Composting, Source Separated Organics Treatment, Biosolids Heat Treatment and Composting.

The Company’s SusGro™ pathogen free organic fertilizer offers an economical, sustainable and highly effective alternative to traditional fertilization. SusGro™ is an organically-based, concentrated organic pathogen free liquid fertilizer product. It has a full complement of nutrients suitable for a broad spectrum of fertilization requirements.

In addition, SusGlobal Energy’s Earth’s Journey™ Compost enhances plant growth. The Company employs patented technology to transform organic waste into the most nutrient-rich organic compost, diverting organic waste from landfills and lessening Greenhouse Gas (GHG) emissions.

Recently, SusGlobal Energy announced that its wholly-owned subsidiary, SusGlobal Energy Belleville Ltd. (SusGlobal Belleville), executed a non-binding Letter of Intent (LOI) for certain assets, including 39.44 acres of property located at 704 Phillipston Road, in Belleville, Ontario. Subject to the execution of an Asset Purchase Agreement (APA), the LOI sets out the terms, including the purchase price of USD$1,332,153 (CAD$1,767,250) in cash to be paid on closing, minus the sum of USD$54,274 (CAD$72,000) advanced by SusGlobal Energy to the seller on February 5, 2019.

If the APA is signed, SusGlobal Belleville will become the owner of the 39.44 land parcel and no more a lessee of the existing 13.88-acre section. SusGlobal Belleville will be expanding the site capacity to 70,000 tonnes per annum from the present 35,000 tonnes per annum composting facility to continue producing its Earth's Journey™ Compost, with an additional 50,000 tonnes per annum organic processing and transfer site approved under the existing Environmental Compliance Approval (ECA) and Site Plan.

Mr. Marc Hazout, Executive Chairman and President of SusGlobal Energy, stated, "We are very pleased to be able to enter into an LOI to purchase this large parcel of land with the ECA attached in order to expand our Belleville site to bring the Ontario, Quebec and New York State organic waste management systems to a sustainable level by diverting from landfills."

SusGlobal Energy Corp. (SNRG), closed Saturday's trading session at $0.015, up 141.9355%, on 97,621 volume with 13 trades. The average volume for the last 3 months is 103,618 and the stock's 52-week low/high is $0.005499999/$1.51999998.

Rainforest Resources, Inc. (RRIF)

High Rising Stocks, OTC Markets, Stockhouse, InvestorsHub, 4-Traders, TradingView, Simply Wall St, Wallet Investor, Barchart, MarketWatch, YCharts, Penny Stock Hub, Wallmine, Stockopedia, Stockflare, Investing News Alerts, and Wall Street Pennies reported earlier on Rainforest Resources, Inc. (RRIF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Rainforest Resources, Inc.’s mission is to protect the ecosystems of the rainforest to reduce the impact of global warming. Rainforest Resources operates in the forestry sector. As part of its dedication to prevent global warming, the Company is making the best of efforts to preserve the rainforest, the initial phase being the “Huamboya Forest” Morona Santiago – Ecuador. At Huamboya, millenary trees and endemic species of the Amazon, terrestrial, aquatic, as well as aerial are found. Rainforest Resources has its U.S. office in Anna Maria, Florida.

The Company, in its dedication to ease global warming, commits all its efforts and economic support for the conservation of the humid forest. Furthermore, it produces carbon credit certificates and develops and exports natural spring water.

Rainforest Resources’ positions are in tropical rain forests, land for reforestation, and above all clean air. The Company’s vision is to sustain forestry and to live in harmony with forestry in itself.

Rainforest Resources is interested in conserving the Huamboya ecosystem. Huamboya presents a Humid Tropical Megathermal climate. The forest is covered by native forest without human intervention.

The Huamboya forest has about 586 endemic plant species of which 45 percent are orchids. The forest has a rich diversity of animal life. This includes 343 species of birds, 100 species of mammals, and more than 500 species of vertebrates.

Recently, Rainforest Resources announced, by way of its subsidiary Rain Forest Enterprises SA, that it purchased from Latitude Aerospace Solutions (LAS) a state of the art Drone model VTOL. When fitted with remote sensors, the Drone can detect the effect of greenhouse gases in a given area and provide data on CO2 and Oxygen levels. This is important information used in the computation for the issuance of Verified Emission Reductions (VERs)/Certified Emission Reductions (CERs).

The initial use of the Drone will be in the evaluation of Rainforest Resources’ rain forest properties in Ecuador to produce Verified Carbon Credit Certificates. Subsequently, it is the Company’s intention to provide the Drone services to other entities involved in the ecological preservation of the rainforests in Ecuador on a cost-plus basis. This will provide additional income to Rainforest Resources.

Rainforest Resources, Inc. (RRIF), closed Saturday's trading session at $2.51, up 48.5207%, on 20,206 volume with 78 trades. The average volume for the last 3 months is 15,301 and the stock's 52-week low/high is $1.17999994/$7.5999999.

LD Holdings, Inc. (LDHL)

Tip.us, Wall Street Reporter, pressreleasepoint,  Innovative Marketing, and Stock Guru reported previously on LD Holdings, Inc. (MRMD), and we report on the Company today, here at the QualityStocks Daily Newsletter.

LD Holdings, Inc. is a Financial and Management Holding Company listed on the OTC Markets Group’s OTCQB. Its focus is on acquiring businesses owned by Boomers who do not have an exit strategy. The Company’s emphasis is on delivering venture capital level returns without the venture capital level risk.  LD Holdings (formerly known as Leisure Direct, Inc.) is based in Perrysburg, Ohio.

LD Holdings focuses on providing marketing, sales, and other business services, which represent target services to position client companies for sales and profit growth in preparation for their eventual sale. In addition, the Company focuses on maintaining a database of businesses for sale; maintaining a database of individuals with specific backgrounds and expertise for acquisition, evaluation, and strategizing the post-acquisition business model; and maintaining a database of investors. 

LD Holdings will also maintain a database of young entrepreneurial managers. The Company will maintain a database of talented individuals with varied specific backgrounds. This will allow it to have expertise available for acquisition evaluation, and strategizing the post-acquisition business model for each potential acquisition,  upon the financial aspects of the transaction being  ascertained.

Furthermore, LD Holdings will look to acquire companies that have an existing management base that can assist in the transition to grow organically and profitably. Also, it will maintain and expand a database of investors to help finance acquisitions.

LD Holdings’ is focusing its immediate and near-term actions on executing a round of five acquisitions in the landscape architect, build and servicing space; implementing a transition and integration plan for newly acquired businesses; delivering revenue growth and operational efficiency targets; and positioning the public entity of LD Holdings for potential exchange up-listing and long term financial success.

The Company works to source Boomer businesses that fit LD Holdings’ acquisition criteria. LD Holdings will source and locate businesses with sales less than $25 million, profitable for the last 3 to 5 years, or have a well-defined path to profitability.

LD Holdings’ plan is to finance its goals via the use of a qualified and screened database of up to 3,000 accredited investors (Angels and Institutions) and 1,500 non-credited investors.

LD Holdings, Inc. (MRMD), closed Saturday's trading session at $0.0002, up 100.00%, on 8,000 volume with 2 trades. The average volume for the last 3 months is 441 and the stock's 52-week low/high is $0.000099999/$0.059.

PEN, Inc. (PENC)

DreamTeamNetwork, Outcast Traders, and SmallCapVoice reported earlier on PEN, Inc. (PENC), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

OTCQB-listed, PEN, Inc. is an international leader in developing, commercializing, and marketing enhanced-performance products enabled by nanotechnology. PEN stands for Products Enabled by Nanotechnology. Products from its family of companies are for healthcare to homecare, homeland defense to food security, and transportation to recreation. PEN has its head office in Miami, Florida.

PEN is the combination of Nanofilm, Ltd. and Applied Nanotech Holdings, Inc. These are two nanotechnology innovators. PEN formed to channel the potential of nanotechnology in real-world products for real-world users. With the combination of these two companies, PEN provides nano-layer coatings, nano-based cleaners, as well as nano-composite products.

PEN’s Applied Nanotech, Inc. subsidiary is based in Austin, Texas. It functions as the Design Center conducting contract services for government and private customers and new product development for PEN centering on inventive and advanced product solutions in the areas of safety, health, and sustainability.

Applied Nanotech Holdings (the PEN Design Center) has over 25 years in the industry. It holds in excess of 250 patents. It has partnered with organizations like the U.S. Department of Transportation, the Army Research Office, and the U.S. Department of Agriculture to find nanotechnology-based solutions to challenges.

PEN, via its wholly-owned subsidiary PEN Brands LLC (formerly Nanofilm Ltd.), develops, manufactures, and sells products based on nanotechnology. This includes its Ultra Clarity® brand eyeglass cleaner, CLARITY DEFOG IT™ brand defogging products, CLARITY ULTRASEAL® nanocoating products for glass and ceramics, and an environmentally friendly surface protector, fortifier, and cleaner.

PEN, Inc. (PENC), closed Saturday's trading session at $0.76, up 33.427%, on 13,393 volume with 18 trades. The average volume for the last 3 months is 995 and the stock's 52-week low/high is $0.400000005/$1.15999996.

The QualityStocks Company Corner

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Pacific Rim Cobalt Corp. (OTCQB: PCRCF).

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (FRANKFURT: NXFE) is pleased to announce it has received approval from the OMBUDSMAN of the Republic of Indonesia for the registration of the Cyclops Nickel-Cobalt Project license in the Directorate General of Minerals and Coal and the Ministry of Energy and Mineral Resources of the Republic of Indonesia.

Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.

Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.

“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”

Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed Saturday's trading session at $0.18905, up 12.7983%, on 60,848 volume with 14 trades. The average volume for the last 3 months is 18,803 and the stock's 52-week low/high is $0.079999998/$0.259299993.

Recent News

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives that offer insights into various companies and their operations and future outlooks. To view the full press release, visit http://cnw.fm/It0Jf.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Saturday's trading session at $0.147, up 5.00%, on 14,950 volume with 7 trades. The average volume for the last 3 months is 54,137 and the stock's 52-week low/high is $0.119999997/$0.51999998.

Recent News

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms and one of the few companies active in the field of cannabis to have developed formal relationships with Fortune 500 industry leaders, is experiencing strong demand from many companies requesting pre-processed DehydraTECH(TM)-enhanced bulk powders.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Saturday's trading session at $0.50, up 0.502513%, on 43,290 volume with 40 trades. The average volume for the last 3 months is 103,088 and the stock's 52-week low/high is $0.3037/$1.57000005.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG), a diversified holdings company, is elevating the lives of its independent representatives toward happiness, health and wealth. An article discussing the company reads, “Community is an essential aspect in the growth of Elepreneurs that is linked to their success and overall happiness. To view the full article, visit http://nnw.fm/YEe5w

Sharing Services Global Corporation (SHRG), formerly Sharing Services Inc., is a diversified company dedicated to maximizing shareholder value, operating through two primary subsidiaries: Elepreneurs Holdings, a direct-selling company, and Elevacity Holdings, a products company. Headquartered in Plano, Texas, SHRG markets and distributes Elevate-branded health and wellness products through an independent sales force of distributors called Elepreneurs.

Proprietary Products

SHRG’s current exclusive Elevate product offerings are marketed under the Elevacity brand, so named to signify the company’s commitment to elevating lives.

The Elevate health and wellness product line consists of nutraceutical products that SHRG refers to as D.O.S.E., which stands for dopamine, oxytocin, serotonin and endorphins – all of which are key hormones proven to promote happiness and well-being.

Elevacity brand products are carefully formulated, chosen and designed to support a single objective: elevate the happiness and well-being of the consumer.

Global Network of Elepreneurs

Elevacity products are shared and sold by a growing international network of home-based entrepreneurs, called Elepreneurs, operated by Elepreneurs Holdings. This SHRG subsidiary provides basic and advanced programs for both new and experienced entrepreneurs who are focusing on their direct-sales careers.

SHRG’s high-performing independent sales force follows the company’s Blue Ocean selling strategy, an approach that encourages individuals to seek new markets, lead, and to “stop competing and start creating.” The Blue Ocean strategy is based on the book, “Blue Ocean Strategy,” written by Professor Renée Mauborgne, who notes that “the lesson here is that the best defense is offense, and the best offense… is to make a blue ocean shift and create your own blue ocean.”

Following this selling strategy, SHRG’s Elepreneurs are taught that, rather than competing directly in a competitive, direct-selling market, they should focus on making competitors irrelevant and succeeding in an uncontested marketplace.

In addition, SHRG’s Elepreneurs use the interactive, video-based VERB sales-marketing platform developed by Verb Technology Company Inc. The app utilizes proprietary interactive video data collection and analysis technology and provides next-generation customer relationship management, lead generation, and video marketing software applications.

Continued Momentum as Industry Leader

These selling strategies have resulted in sharp and consistent revenue gains. In the company’s 10-Q filed with the SEC for the three months ended Oct. 31, 2019, SHRG reported sales of $38.8 million for fiscal Q2 2019, an increase of 116% over sales of $17.9 million reported for the comparable quarter of 2018. Consolidated gross profit jumped by $16.2 million to $27.4 million for the same period compared to Q2 2018.

SHRG’s consolidated operating earnings were $3.9 million in the fiscal quarter ended Oct. 31, 2019, compared to $866,802 for the comparable period the prior year. Consolidated gross margin also grew 70.9% for the three months ended Oct. 31, 2019, compared to 62.2% the prior year.

These numbers are continuing a trend established over the past two years. In fiscal Q1 2019, SHRG achieved revenues of $35.4 million, more than double that of the comparable period in 2018. Even earlier, the company reported sales of $85.9 million for fiscal year ended April 30, 2019. This represents a nine-fold increase, or $77.5 million jump, over the company’s revenues of $8.4 million the prior year.

These numbers bring SHRG’s sales revenues since December 2017 — when the company’s Elevate product line was released — to an impressive cumulative total of $169 million.

Preparing for Success

SHRG is well prepared to continue and accommodate for this growth. The company recently expanded its corporate footprint by moving to a 10,000-square-foot facility in Plano, Texas, that offers ample room to expand as the company grows and flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

In addition, the company has a seasoned, expert leadership team in place, led by John “JT” Thatch. Thatch was appointed president and CEO of SHRG in March 2018, bringing to the company his expertise obtained from successfully starting, owning and operating several businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist SHRG as the company aims to expand and increase revenues.

Contact
469.304.9400 x 201
Info@SHRGinc.com
http://www.SHRGinc.com

Sharing Services Global Corporation (SHRG), closed Saturday's trading session at $0.1199, up 19.90%, on 1,162,214 volume with 67 trades. The average volume for the last 3 months is 131,003 and the stock's 52-week low/high is $0.065800003/$0.3944.

Recent News

InsuraGuest Inc.

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Inc..

Utah-based InsuraGuest is working to increase its service reach nationwide and internationally to help prevent coverage gaps. A recent article discussing the company reads, “The company’s proprietary InsurTech software platform is being adopted by an increasing number of establishments. The company recently released its wholly owned subsidiary, InsuraGuest Insurance Agency LLC (IG Agency). IG Agency brings licensed insurance sales in-house to increase InsuraGuest revenues and create shareholder value, and is currently available in 16 states, from Maryland to Nevada. InsuraGuest expects to have regulatory approval to sell in all states before the end of the year (http://nnw.fm/2d2JK).  To view the full article, visit http://nnw.fm/cJ9oX

InsuraGuest Inc. is a SaaS (Software-as-a-Service) company utilizing its proprietary flagship InsurTech software platform to provide specialized insurance products to end users in the business-to-business (B2B) and business-to-consumer (B2C) markets. The company’s first focus is on the B2B hotels and vacation rentals sectors, where its API integrates with the clients’ property management systems to offer guests a specialized guest protection policy. The platform and policy combination “InsurTech” product helps transfer the exposure to liability away from the client/property while guests benefit from potential accident and loss coverage during their stay.

InsuraGuest’s platform is currently capable of integrating with approximately 70 different hotel and vacation rental property management systems, giving it access to roughly 40,000 properties worldwide.

The company continues to pursue expansion opportunities and recently signed a Letter of Intent with a master general agent in the United Kingdom and Europe to distribute its platform and products to hotel and vacation rental markets in those regions, as well as plans to expand to Asia in 2020.

Protecting Guests, Enhancing Customer Experience

InsuraGuest is the first line of defense for both the property and the guest.

InsuraGuest is purchased by the hotel or vacation rental “property,” which offers the policy to each registered guest and its occupants for an additional fee. The specialized policy affords coverage for theft of personal property while in the hotel, as well as accidental medical expense and accidental death and dismemberment, up to the policy limits of $2,500 to $50,000.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United State alone, where there are approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s demographics combined will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Specialized Guest Protection Policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Business Highlights

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a BS undergraduate degree in Consumer Studies with an emphasis in Architecture as an undergraduate at the University of Utah. He subsequently earned his Master’s in Business Administration. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends.

Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Christopher J. Panos Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018. He also has served as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.


Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Predictive Oncology (NASDAQ: POAI) recently announced the appointment of Pam Prior, CPA, to the company’s Board of Directors. In addition to holding a seat on the board, Prior will also chair the company’s audit committee. An article further discussing the company reads, “Prior, 57, joins POAI’s Board of Directors with 35 years of experience in accounting, mainly in management as CFO or controller. As the founder and CEO of Priorities Group Inc., a provider of CFO services to small and mid-sized businesses, she has served as a CFO to a number of companies, including Gentris Corp., a private pharmacogenomics company subsequently purchased by Cancer Genetics Inc. To view the full article, visit http://nnw.fm/c9VAe

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Saturday's trading session at $2.36, off by 1.6667%, on 56,072 volume with 211 trades. The average volume for the last 3 months is 133,462 and the stock's 52-week low/high is $2.28999996/$8.50.

Recent News

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products (CSE: PLUS) (OTCQB: PLPRF), a branded, cannabis-infused, products manufacturer of edibles created to support a healthy and active lifestyle, is on a mission to become the world’s strongest cannabis brand. To view the full article, visit http://cnw.fm/NzU8q

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Saturday's trading session at $0.87, off by 0.263671%, on 29,041 volume with 30 trades. The average volume for the last 3 months is 47,344 and the stock's 52-week low/high is $0.77759999/$5.77449989.

Recent News

Sigma Labs Inc. (NASDAQ: SGLB)

The QualityStocks Daily Newsletter would like to spotlight Sigma Labs Inc. (SGLB).

Sigma Labs’ (NASDAQ: SGLB) proprietary PrintRite3D(R) software enables both real-time, in-process detection of quality-control manufacturing irregularities and provides operators with actionable information necessary to adjust and mitigate the developing anomaly. To view the full article, visit http://nnw.fm/8W2Uf

Sigma Labs Inc. (SGLB) is the only provider of in-process quality-assurance software to the commercial 3D printing metal industry that enables operators of machines making 3D metal parts to offset emerging quality problems, sustain part quality, and avoid rejects. Sigma’s software is the singular solution that enables both real-time, in-process detection of quality control manufacturing irregularities for critical metal parts and then provides the operator the actionable information needed to adjust and mitigate the developing anomaly. Sigma Labs’ software represents a paradigm shift in the quality control process for the manufacture of 3D printed metal components. The nascent 3D metal printing industry is on the verge of radically altering the speed and technical complexity of manufactured parts. Further, it makes possible just-in-time availability of critical components – all at reduced cost, time, waste and weight. 3D printing, heralded as the fourth industrial revolution in manufacturing, will only truly surpass traditional techniques when the additive manufacturing industry moves from “post process” quality control to “in process” quality assurance.

For the industry to move from prototype manufacturing of critical components to economically viable commercial production, the 3D metal printing industry must find ways to dramatically increase production speed and quality yields, and to dramatically decrease the excessive cost of quality control. To achieve these prerequisites and move 3D metal printing into the mainstream, parts must be inspected and certified during the manufacturing process rather than after. Parts in the production process that are developing signs of quality control problems must be identified in real-time and alerts must be issued. The problem, along with the solution, must then be communicated to the machine operator to implement repairs.

Revolutionizing Additive Manufacturing

Sigma Labs, with its PrintRite3D® brand, has established a new benchmark in the development and commercialization of real-time computer aided inspection (“CAI”) solutions. Sigma Labs resolves the major roadblocks and costly quality control challenges that impede the 3D manufacture of precision metal parts. The company’s breakthrough computer-aided software product revolutionizes commercial additive manufacturing, enabling non-destructive quality assurance during production, uniquely allowing errors to be corrected in real-time.

Sigma Labs was founded in 2010 by a team of Los Alamos National Labs scientists and engineers to develop and commercially license advanced metallurgical products for the military ordinance, dental implants, and then for additive manufacturing (3D printing). After assessing 3D metal printing technology and the costly, inconsistent quality control issues, Sigma Labs concluded that the enormous potential of 3D metal printing could only scale up if in-process quality-assurance tools were developed to observe, manage and control the manufacturing complexities in such a manner that reliability and repeatability of very high precision quality metal parts could be achieved in the process. Sigma Labs’ patented and third-party validated software has achieved these objectives and now delivers the critical elements needed to unleash the promise of 3D metal printing.

Sigma Labs’ products and services are engineered, manufactured and qualified for use in the highly demanding and hyper precise production environments of the aerospace, defense, transportation, oil and gas, biomedical and other precision-dependent industries.

The Challenge

Additive metal manufacturing combines multiple processes and parts into one single 3D printed part. Due to variances in the additive manufacturing process, parts of consistent quality currently can’t be reliably produced in either large or small quantities without substantial postproduction inspection and rejection costs. Parts are inspected after production using CT scans and other means, so the manufacturer doesn’t know until the very end which of the finished parts meet design specifications. This means lost time, lost profits and inability to economically scale up production.

Innovative Approach

Sigma Labs solves this problem with its patented, in-process quality control technology that informs operators and engineers how to improve both the manufacturing process and quality by capturing meaningful data about inconsistencies in real-time. Sigma Labs is also partnering with OEMs, working toward the visionary introduction of revolutionary closed-loop control that will bypass the machine operator and automatically make in process corrections by reducing machine variations.

Sigma Labs’ next generation technology gives manufacturers the ability to make fast, virtual real-time adjustments so that each finished part is uniform and within critical specifications, thereby improving production quality, decreasing end-users’ risks and waste, and increasing profits and speed to market. Sigma Labs’ PrintRite3D® IPQA Software monitors and assesses the quality of each production part in the 3D additive manufacturing process – layer by layer, and in real-time. This has never been available until now.

Sigma Labs maintains a strong intellectual property portfolio consisting of trade secrets, process know-how and 34 patents either granted, pending or awaiting pre-publication around the globe. These patents encompass the fundamental technologies underlying Sigma Labs’ melt pool process control, data analytics, anomaly detection, signature identification, and future “closed-loop control” of 3D metal printing.

Market Opportunity

Providing advanced quality assurance software to the commercial 3D printing industry is currently a $1.4 billion addressable market expected to grow to $3.9 billion by 2023. Integrating Sigma Labs’ groundbreaking software helps arm the industry with a necessary catalyst to help enable and optimize the fourth industrial revolution in manufacturing.

Sigma Labs’ global client base includes 23 installations across 19 different users. Tier-1 OEM enterprises and end-users such as Siemens, Honeywell, Pratt & Whitney and others are currently evaluating PrintRite3D® for production lines.

Management Team

John Rice, CEO and chairman of the board of directors, has extensive experience as a CEO, lead negotiator, turnaround expert, business financier and crisis management executive/consultant. Prior to becoming chair and CEO of Sigma Labs, he was the CEO of a successful turn-around of a Coca-Cola Bottling Company. Rice has led a variety of companies in diverse business sectors and worked on a host of products and technologies including design and manufacture of high-end jet engine test equipment for the U.S. Airforce, chaff dispensers for F16s, software for modeling naval exercises, software for controlling warehouse distribution systems, medical radioisotopes, cancer detection, and cybersecurity. He is an honor’s graduate of Harvard College.

Darren Beckett, CTO, has over 20 years of experience in the semiconductor industry, including Intel Corporation, where he held various technical and managerial positions. His expertise in process engineering for advanced manufacturing technology includes statistical process control for fabrication of semiconductor devices.

CFO Frank D. Orzechowski also serves as treasurer, principal accounting officer, principal financial officer and corporate secretary. He has more than 30 years of distinguished financial and operational experience. Orzechowski began his career at Coopers & Lybrand in 1982, received his CPA certification in 1984, and received his Bachelor of Science in Business Administration with a major in accounting from Georgetown University in 1982.

Ronald Fisher, vice president of business development, is leading the commercialization of PrintRite3D® 5.0. Fisher is a mechanical engineer with hands-on experience in quality, manufacturing and product development. He has distinguished himself as a lead sales and marketing officer as well as a chief operating officer most recently before joining Sigma in technology startup that grew from market entry to successful exit by merger-acquisition.

Sigma Labs Inc. (SGLB), closed Saturday's trading session at $0.87, off by 10.549%, on 124,047 volume with 235 trades. The average volume for the last 3 months is 101,900 and the stock's 52-week low/high is $0.451099991/$2.45000004.

Recent News

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint (OTCQB: SING) today announced that it was featured in a report from Ludlow Research (http://nnw.fm/r3DcR). To view the full press release, visit http://nnw.fm/Kq54Z. Also today, the company was highlighted in a publication from HempWireNews. SinglePoint was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. To view the full press release, visit http://cnw.fm/wFfQ2

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Saturday's trading session at $0.0097, off by 11.8182%, on 19,942,200 volume with 348 trades. The average volume for the last 3 months is 3,183,236 and the stock's 52-week low/high is $0.007/$0.023.

Recent News

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases, recently announced its entry into an exclusive license agreement with the University of Pittsburgh for a diabetes gene therapy that may have the potential to cure Type 1 and Type 2 diabetes, which together currently affect approximately 30.3 million people in the U.S., or 9% of the U.S. population. To view the full press release, visit http://nnw.fm/A5oN0

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Saturday's trading session at $4.28, up 56.2044%, on 83,976,853 volume with 297,330 trades. The average volume for the last 3 months is 4,394,087 and the stock's 52-week low/high is $0.231000006/$5.75.

Recent News

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT)

The QualityStocks Daily Newsletter would like to spotlight Blue Hat Interactive Entertainment Technology (BHAT).

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of augmented reality interactive entertainment games, toys and educational materials in China, today announced the launch of “Smart Immersive Physical Education Classes,” an innovative smart product that integrates education with technology. To view the full press release, visit http://nnw.fm/7nV79

Blue Hat Interactive Entertainment Technology (BHAT) is a cutting-edge creator, developer and operator of popular augmented reality (“AR”) interactive smart toys and educational games in China. Blue Hat’s mobile-connected entertainment platform connects physical items to mobile devices through wireless technologies, creating a unique interactive user experience in various mobile games, interactive educational materials and toys with mobile game features.

Blue Hat designs original toys and games that utilize augmented reality technology, motion capture technology, image recognition technology, voice control, light sense technology, infrared, levitation induction, and other trending scientific technologies to transverse the virtual with reality. Blue Hat creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. This combination provides users with a more natural form of human computer interaction, enhances a user’s perception of reality, and delivers a more immersive entertainment experience.

Proprietary Technology

Founded in 2010, Blue Hat’s proprietary technology, product research and development, marketing channels and brand operation are the cornerstones of the business. Blue Hat focuses on the combination of “online” and “offline” activity and the interaction between “entertainment” and “product” to create a high-tech entertainment platform combining mobile games and AR. With the help of computer graphics, motion capture technology, image recognition technology and visualization technologies, Blue Hat accurately “places” virtual objects into the physical world, creating a new and stimulating visual environment for users.

Blue Hat recently displayed a variety of its sci-tech products at the Guangzhou International Toy Exhibition in China including AR Racer, Elastic Bubbles, AR Space Track, AR Alloy Toy Car, AR Need a Spanking, 5D Animated Magic Aquarium, Bug Travelers, AR Picture Book and other interactive games and smart toys.

The company has multiple products in development including new generations of four primary product lines and two new product lines.

Patents and Copyrights

Blue Hat’s advanced AR technology in interactive entertainment is protected by 178 authorized patents with 44 patents in various stages of the application process.

Another 14 applications for Patent Cooperation Treaty, or PCT, have been filed for international patents. As of March 31, 2019, the company owns 645 copyrights for artwork, 71 registered trademarks and 27 software copyrights.

Sales and Marketing

There has been rapid growth in the toys and games industry in China over the last several years. Total retail sales of toys and games in China soared from RMB 111.8 billion in 2012 to RMB 276.5 billion in 2017 with an average annual growth rate of 19.9% in 2017. Blue Hat believes the company is well positioned with little competition as the toy industry rapidly shifts toward intelligent and interactive toys and games. Retail sales of electronic toys grew at 24% annually in 2017 while that of traditional toys grew at 7%.

In addition to a powerful ecommerce presence, Blue Hat has long-term relationships with partnered distributors that place the company’s AR interactive entertainment products into well-known international retail chains and retail outlets. Blue Hat’s integrated online and offline sales channels include e-commerce giants such as Amazon and Alibaba, retail chain stores and the company’s physical experience store located in Xiamen, China. Blue Hat plans to open or franchise approximately 100 additional stores in China by 2021.

Blue Hat’s community-based platform offers users a highly engaged and interactive community with online communication forums and offline social activities. The company advocates a new model of “teaching through lively activities” and combines AR technology with education, integrating its products into situational teaching, roleplaying and man-machine interaction. This novel educational experience helps realize optimal transformation of information, creating a knowledge and enhancing cognition.

Management

Director and CEO Xiaodong (Sean) Chen has over 20 years of experience creating, developing and producing toys and games related products. Chen earned his EMBA from Renmin University of China and has been chairman of the board of directors and general manager of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

CFO and Director Caifan, who has over 20 years of financial accounting and taxation experience, earned a degree in finance from Hunan University of Finance and Economics. He has served as director, deputy general manager and financial controller of Fujian Blue Hat Interactive Entertainment Technology Ltd. since August 2015.

Jianyong Cai, chief technology officer and director, has over 35 years of experience in data communication principles, communication network foundation, software engineering, communication network theory and technology and computer network architecture. He holds degrees in data communication principles, communication network foundation and software engineering from University of Science and Technology of China. He has been director, deputy general manager and chief engineer of Fujian Blue Hat Interactive Entertainment Technology Ltd. since January 2010.

Blue Hat Interactive Entertainment Technology (BHAT), closed Saturday's trading session at $1.16, off by 5.6911%, on 49,629 volume with 379 trades. The average volume for the last 3 months is 80,048 and the stock's 52-week low/high is $1.05999994/$6.25.

Recent News

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today released its financial results for the three and nine months ended December 31, 2019. According to the update, the company’s unaudited condensed interim consolidated financial statements as well as its management's discussion and analysis (“MD&A”) for Q3 2020 are available under the company's profile SEDAR at www.SEDAR.com and on the company's website. To view the full press release, visit http://cnw.fm/0l77G. Also today, the company was highlighted in the Investor Ideas Potcast, from Investorideas.com. Listen to the podcast: http://ibn.fm/NblCu.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (CNPOF), closed Saturday's trading session at $0.8419, off by 5.933%, on 217,893 volume with 237 trades. The average volume for the last 3 months is 116,425 and the stock's 52-week low/high is $0.779999971/$3.99.

Recent News

The Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) on Thursday announced its financial and operating results for the three and six months ended December 31, 2019, as well as an update on its strategy and outlook. In addition, Thursday marked the announcement of Supreme Cannabis’ entry into a landmark sales agreement with Humble & Fume Inc. ("humble+fume"), one of North America's leading distributors of cannabis accessories. To view the full press releases, visit http://cnw.fm/0YEYc and http://cnw.fm/khX4a. Also today, the company was highlighted today in a publication from Investing News Network, examining how, like others in the space, The Supreme Cannabis Company decided to let go of some of its staff in an effort to cut costs amid market uncertainty.

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Saturday's trading session at $0.28014, off by 9.184%, on 1,153,392 volume with 463 trades. The average volume for the last 3 months is 494,941 and the stock's 52-week low/high is $0.279199987/$1.75.

Recent News

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF)

The QualityStocks Daily Newsletter would like to spotlight Siyata Mobile Inc. (SYATF).

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) will present for the upcoming Virtual Investor Conference, the leading proprietary investor conference series where company executives share vision and answer audience questions at VirtualInvestorConferences.com. To view the full press release, visit http://nnw.fm/h4uLE

Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) is a leading global developer and provider of Push-to-Talk Over Cellular ("PTT/PoC") systems for enterprise customers. The company specializes in connected vehicle products for professional fleets and markets its products under the Uniden® Cellular brand.

Since its inception in 2012, Siyata has amassed a customer base that includes cellular operators, commercial vehicle technology distributors, and fleets of all sizes in Canada, the U.S., Europe, Australia and the Middle East.

Recognized by the Toronto Venture Stock Exchange in 2018 as a Venture Top 50 Company, Siyata aims to deliver the highest quality and most technologically advanced mobile communication devices for global corporate workforces, fleets, homes and buildings.

The company has long been an industry pioneer, delivering the world's first 3G connected vehicle device as well as the world's first 4G/LTE vehicle mounted smartphone for First Responders and commercial fleets and vehicles.

Siyata is headquartered in Montréal, Québec, Canada.

Product Portfolio

Siyata's suite of technology includes numerous PTT and legacy devices, as well as cellular boosters designed to improve cellular signals in corporate warehouses, government embassies, retirement home campuses, banks and manufacturing plants.

The company's flagship product, the Uniden UV350, is the world's first vehicle-mounted 4G/LTE smartphone with crystal clear quality, carrier grade PTT, voice, text, video and data applications built into a single device. Specifically designed for First Responder and commercial fleet vehicles, the UV350 runs on cellular LTE networks that provide nationwide and global coverage, replacing traditional single purpose two-way radios that require a monthly fee and limited network coverage.

The Uniden UV350 is currently available through Bell Mobility, Canada's largest LTE network and PTT community. Expanding its availability, Siyata is completing network approval with two North American Tier 1 operators to launch the UV350 in the U.S. in 2019.

Management Team

CEO and Chairman Marc Seelenfreund is the founder of Siyata. He is also the founder of Siyata's parent company, Accel Telecom, an Israel-based company that specializes in importing and distributing innovative cellular and IP devices to fixed line operators and mobile providers within Israel. Prior to establishing Accel, Seelenfreund was a vice president at Sunrise Corporation in New York where he focused on financing publicly traded technology companies. Seelenfreund has a law degree from Bar Ilan University, is a board member at Israel's leading private university, and has served as an officer in the Israel Defense Forces.

Glenn Kennedy, vice president of sales, has over 25 years of sales experience in the telecommunications industry. Prior to joining Siyata in 2016, Kennedy managed sales nationally for Motorola Canada, HTC Communications Canada, and Sonim Technologies. He holds a bachelor's degree in honors business administration from the Richard Ivey School of Business at the University of Western Ontario.

CFO Gerald Bernstein, a professional chartered accountant, has spent 20 years focusing on private equity financing and tax efficient corporate structuring in multi-jurisdictional arenas. He holds a bachelor's degree of commerce as well as a graduate diploma in public accountancy from McGill University. Bernstein has been a member of the Canadian Institute of Chartered Accountants since 1987.

Gidi Bracha, Vice President of Technology, has served in this position since 2011 and spearheaded the development of both the Truckfone, Voyager and UV350. Bracha served in various key positions at Cellcom, Israel's leading cellular provider, including head of car mobility products and director of type approvals. Bracha served as an engineer technician in the Anti-Aircraft division of the Air Force in the Israel Defense Forces and holds a bachelor's degree in engineering and business management from the University of Derby.

Siyata Mobile Inc. (SYATF), closed Saturday's trading session at $0.208, off by 5.7544%, on 359,248 volume with 40 trades. The average volume for the last 3 months is 94,765 and the stock's 52-week low/high is $0.198500007/$0.446249991.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.